| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |